Jim Simons I Teos Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 645,600 shares of ITOS stock, worth $5.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

645,600

Previous 837,200 22.89%

Holding current value

$5.51 Million

Previous $6.43 Million 40.05%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$5.97 - $8.15 $1.14 Million - $1.56 Million	-191,600 Reduced 22.89%	645,600 $3.85 Million
Q4 2024 Feb 13, 2025	BUY	$7.22 - $10.02 $2.17 Million - $3.01 Million	300,800 Added 56.08%	837,200 $6.43 Million
Q3 2024 Nov 13, 2024	SELL	$10.09 - $17.97 $234,088 - $416,904	-23,200 Reduced 4.15%	536,400 $5.48 Million
Q2 2024 Aug 09, 2024	SELL	$10.33 - $18.09 $1.63 Million - $2.85 Million	-157,700 Reduced 21.99%	559,600 $8.3 Million
Q1 2024 May 13, 2024	BUY	$9.89 - $13.64 $181,976 - $250,976	18,400 Added 2.63%	717,300 $9.78 Million
Q4 2023 Feb 13, 2024	BUY	$8.57 - $11.06 $2.61 Million - $3.37 Million	304,900 Added 77.39%	698,900 $7.65 Million
Q3 2023 Nov 14, 2023	SELL	$10.95 - $14.6 $210,240 - $280,320	-19,200 Reduced 4.65%	394,000 $4.31 Million
Q2 2023 Aug 11, 2023	BUY	$12.93 - $18.05 $1.08 Million - $1.5 Million	83,300 Added 25.25%	413,200 $5.47 Million
Q1 2023 May 12, 2023	BUY	$13.02 - $22.62 $166,656 - $289,536	12,800 Added 4.04%	329,900 $4.49 Million
Q4 2022 Feb 13, 2023	SELL	$17.77 - $21.6 $1.35 Million - $1.64 Million	-75,800 Reduced 19.29%	317,100 $6.19 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $1.13 Million - $1.65 Million	60,600 Added 18.24%	392,900 $7.49 Million
Q2 2022 Aug 12, 2022	BUY	$16.57 - $35.1 $3.28 Million - $6.95 Million	198,100 Added 147.62%	332,300 $6.85 Million
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $3.23 Million - $4.8 Million	101,100 Added 305.44%	134,200 $4.32 Million
Q4 2021 Feb 11, 2022	BUY	$26.23 - $47.86 $868,213 - $1.58 Million	33,100 New	33,100 $1.54 Million

Others Institutions Holding ITOS

# of Institutions

142

Shares Held

36.6M

Call Options Held

121K

Put Options Held

738K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $303M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account